Business Context and Reporting Period
This Form 8-K is a current report filed by WellPoint, Inc. (now Elevance Health, Inc.) on June 11, 2007, regarding events occurring on June 5, 2007. The filing addresses corporate governance and management changes, specifically the approval of compensatory arrangements for a principal officer.
Key Financial Metrics
The filing does not provide consolidated financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data presented relates to the specific compensation package for Wayne S. DeVeydt, Executive Vice President, Chief Financial Officer, and Chief Accounting Officer:
- 2007 Salary: $600,000 (effective June 11, 2007).
- 2007 Annual Bonus Target: 75% of annual salary.
- Promotional Stock Option Grant: 13,333 options.
- Promotional Restricted Stock Unit (RSU) Award: 1,667 units.
Material Changes Versus Prior Period
The filing reports a material change in the compensation structure for the Chief Financial Officer effective June 11, 2007. This includes a new salary rate, a defined bonus target percentage, and the granting of promotional equity awards. No comparative financial performance data against prior periods is included in this document.
Guidance, Outlook, and Management Commentary
The filing outlines the performance measures tied to the 2007 Annual Incentive Bonus for the CFO:
- Adjusted diluted Earnings Per Share (40% weight).
- Operating Gain (20% weight).
- Specialty Performance (15% weight).
- Medical Membership Growth (15% weight).
- Member Health Index (5% weight).
- Member Trust (5% weight).
Contingencies and Vesting Terms:
- Bonus Threshold: No bonus is paid if the threshold adjusted diluted Earnings Per Share is not achieved.
- Bonus Cap: Maximum cash award is 200% of the target; amounts exceeding this are paid in RSUs vesting over three years.
- Option Vesting: 13,333 options vest in six equal semi-annual installments over three years beginning January 2, 2008.
- RSU Vesting: 1,667 RSUs vest in three equal annual installments over three years beginning July 2, 2008, contingent on 2007 adjusted diluted Earnings Per Share meeting a specified threshold.
Investor Verification Checklist
- Verify the exact closing price of WellPoint stock on July 2, 2007, to determine the exercise price of the 13,333 stock options.
- Confirm the specific threshold amount for adjusted diluted Earnings Per Share required to trigger the 2007 bonus and RSU vesting.
- Review subsequent filings to confirm whether the 2007 performance targets were met and the resulting payout amounts.
- Note that the company name listed in the filing is WellPoint, Inc., which later became Elevance Health, Inc.